AriBio secures $27.5 million strategic investment from Fosun Pharma, enhancing their partnership for AR1001, an oral Alzheimer's drug.
Amount Raised
$27.5 Million
Round Type
Corporate Round
South KoreaBiotechnologyHealth CareTherapeuticsInvestors
Description
AriBio has secured a strategic equity investment of $27.5 million from Fosun Pharma, transforming a licensing deal into a shareholder relationship. The investment will be deployed in two stages, supporting the development of AR1001. This partnership is notable in the Korean biotech industry for its quick evolution. The funding comes as AriBio completes patient dosing in its global Phase 3 trial for AR1001.
Quick answer
ARIBIO raised $27.5 Million in a Corporate Round round, dated July 3, 2026. Investors: Fosun Pharma. ARIBIO is based in South Korea.
- How much did ARIBIO raise?
- ARIBIO raised $27.5 Million in a Corporate Round round on July 3, 2026.
- Who invested in ARIBIO?
- Fosun Pharma is named as investors in this round.
- What does ARIBIO do?
- ARIBIO is a biotechnology company focused on developing innovative solutions in the medical field.
- Where is ARIBIO based and how big is it?
- ARIBIO is based in South Korea. Fundz records about 42 employees.
- Who are the decision-makers at ARIBIO?
- Fundz holds 1 contact at ARIBIO, including the Senior Medical Director, Clinical Development. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Therapeutics and Biotechnology around the same time
Companies in the same sectors as ARIBIO that raised within 45 days of this round, from Fundz verified event records.
- Apollomics raised $10M on August 14, 2026.
- bioAffinity Technologies raised $4M (Post-IPO Equity) on August 14, 2026.
- Khartis Therapeutics raised $50M (Series B) on August 13, 2026.
- Amplifica Holdings Group raised $26M (Series B) on August 12, 2026.
- InduPro raised $77M (Series B) on August 12, 2026.
- Vaderis Therapeutics raised $152M (Series B) on August 11, 2026.
Who to call at ARIBIO, and when
A new round usually means ARIBIO is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day ARIBIO raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at ARIBIO, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at ARIBIO. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment ARIBIO raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
ARIBIO raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.